{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:40:21Z","timestamp":1791463221491,"version":"4.3.4"},"reference-count":19,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s279364","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T22:48:36Z","timestamp":1610491716000},"page":"129-140","source":"Crossref","is-referenced-by-count":19,"title":["Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"John","family":"Sheppard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4634-9542","authenticated-orcid":true,"given":"Jodi","family":"Luchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abayomi","family":"Ogundele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1390-2532","authenticated-orcid":true,"given":"Paul","family":"Karpecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2015.0071","volume":"112","author":"Messmer","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S113437","volume":"11","author":"Rhee","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2017.03.006","volume":"117","author":"Lallemand","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1023\/A:1013671819604","volume":"19","author":"Kuwano","year":"2002","journal-title":"Pharm Res"},{"key":"ref10","unstructured":"CEQUATM (cyclosporine opthalmic solution 0.09%). Full prescribing information. Cranbury, NJ: Sun Pharmaceutical Industries, Inc.; 2018."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.4.3.1","volume":"4","author":"Cholkar","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/jop.2018.0106","volume":"35","author":"Weiss","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2147\/OPTH.S175065","volume":"12","author":"Bacharach","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.ophtha.2019.03.050","volume":"126","author":"Goldberg","year":"2019","journal-title":"Ophthalmology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1097\/ICO.0000000000001989","volume":"38","author":"Malhotra","year":"2019","journal-title":"Cornea"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1089\/jop.2018.0154","volume":"35","author":"Smyth-Medina","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/ICL.0000000000000636","volume":"46","author":"Sheppard","year":"2020","journal-title":"Eye Contact Lens"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2147\/OPTH.S115098","volume":"12","author":"Deveney","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"ref19","unstructured":"RESTASIS\u00ae (cyclosporine ophthalmic emulsion) 0.05% for topical ophthalmic use. Full prescribing information. Irvine, CA: Allergan; 2017."}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=65636","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=65636","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T22:48:41Z","timestamp":1610491721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/phase-3-efficacy-worse-eye-analysis-and-long-term-safety-evaluation-of-peer-reviewed-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":19,"URL":"https:\/\/doi.org\/10.2147\/opth.s279364","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}